Bio-Rad Laboratories, Inc.
Laboratory Analytical Instruments- 売上
- $2.6bn
- 時価総額
- $8.9bn
株価 $326.72 · 100株 3万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $2.7bn | $2.6bn | $2.6bn |
| 成長率 | — | ▲3.9% | 0.7% |
| 総利益 | $1.4bn | $1.4bn | $1.3bn |
| 総利益率 | 53.4% | 53.7% | 51.9% |
| 販管費 | $842m | $814m | $844m |
| 販管費率 | 31.5% | 31.7% | 32.7% |
| 営利 | $338m | $269m | $47m |
| 営利率 | 12.6% | 10.5% | 1.8% |
| 純利益 | ▲$637m | ▲$1.8bn | $760m |
| PBR | 1.0 | 1.4 | 1.2 |
| PSR | 3.3 | 3.5 | 3.4 |
| PGPR | 6.2 | 6.5 | 6.6 |
| PER | — | — | 12 |
| ネットキャッシュ | ▲$795m | ▲$712m | ▲$680m |
| EV/EBITDA | 20.1 | 22.9 | 45.1 |
| Rule of 40 | — | 7% | 3% |
| セールス効率 | — | — | ▲129% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
